← Open Payments lookup

SAM CHERIAN: Open Payments

NPI 1972208726 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,639 in 66 payments from 14 companies in 2025. Trend: 2023 $1,051 · 2024 $725 · 2025 $1,639

Food & beverage: $1,540Education: $99
CompanyPaymentsAmount
ABBVIE INC.26$520
AstraZeneca Pharmaceuticals LP9$207
Astellas Pharma US Inc5$168
Amgen Inc.2$139
Teva Pharmaceuticals USA, Inc.1$135
Axsome Therapeutics, Inc.4$118
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$91
Lilly USA, LLC4$61
SHIELD THERAPEUTICS INC3$61
Novo Nordisk Inc2$44

Products named: VRAYLAR, KRYSTEXXA, AUSTEDO XR, Auvelity, FARXIGA, CAPLYTA, Veozah, AIRSUPRA.

Industry payments across TX — which companies pay providers there.